IXICO (LON:IXI) Share Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of IXICO plc (LON:IXI) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.57 and traded as low as GBX 8. IXICO shares last traded at GBX 8, with a volume of 6,847 shares.

IXICO Trading Down 4.7%

The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The firm has a fifty day simple moving average of GBX 8.44 and a 200-day simple moving average of GBX 8.54. The firm has a market cap of £17.74 million, a P/E ratio of -4.15, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13.

IXICO (LON:IXI) last released its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) EPS for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The firm had revenue of GBX 395 million for the quarter. On average, equities research analysts expect that IXICO plc will post -289.3584879 earnings per share for the current year.

Insider Transactions at IXICO

In other IXICO news, insider Mark Warne purchased 50,006 shares of the firm’s stock in a transaction on Wednesday, July 15th. The stock was acquired at an average price of GBX 8 per share, for a total transaction of £4,000.48. Insiders own 3.05% of the company’s stock.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.